Dominic J. Caruso net worth and biography

Dominic Caruso Biography and Net Worth

VP of Johnson & Johnson

Mr. Caruso retired as executive vice president and chief financial officer from Johnson & Johnson in August 2018, having served in the role since 2007. He led the company’s financial and investor relations activities, as well as the procurement organization. Mr. Caruso joined Johnson & Johnson in October 1999 as chief financial officer for Centocor, Inc., upon the completion of the merger of Centocor and Johnson & Johnson. Prior to joining Centocor, he had varied industry experiences with KPMG. Mr. Caruso is actively involved in government relations activities globally, including having served as the co-chair of the U.S. Chamber of Commerce Global Initiative on Health and the Economy. He currently serves on the board of trustees of The Children’s Hospital of Philadelphia, the Cystic Fibrosis Foundation and is on the board of directors for Kyndryl Inc. Mr. Caruso has been a director of the Company since September 2018. He is chair of the Audit Committee and a member of the Compliance Committee.

What is Dominic J. Caruso's net worth?: The estimated net worth of Dominic J. Caruso is at least $37.09 million as of July 20th, 2017. Mr. Caruso owns 226,693 shares of Johnson & Johnson stock worth more than $37,093,776 as of March 28th. This net worth estimate does not reflect any other assets that Mr. Caruso may own. Learn More about Dominic J. Caruso's net worth.
How do I contact Dominic J. Caruso?: The corporate mailing address for Mr. Caruso and other Johnson & Johnson executives is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. Johnson & Johnson can also be reached via phone at (732) 524-0400 and via email at investor-relations@its.jnj.com. Learn More on Dominic J. Caruso's contact information.
Has Dominic J. Caruso been buying or selling shares of Johnson & Johnson?: Dominic J. Caruso has not been actively trading shares of Johnson & Johnson within the last three months. Most recently, Dominic J. Caruso sold 82,591 shares of the business's stock in a transaction on Thursday, July 20th. The shares were sold at an average price of $136.72, for a transaction totalling $11,291,841.52. Following the completion of the sale, the vice president now directly owns 226,693 shares of the company's stock, valued at $30,993,466.96. Learn More on Dominic J. Caruso's trading history.
Who are Johnson & Johnson's active insiders?: Johnson & Johnson's insider roster includes Dominic Caruso (VP), Robert Decker (CAO), Joaquin Duato (CEO & Chairman), Peter Fasolo (VP), Alex Gorsky (CEO), William Hait (Insider), Ronald Kapusta (CAO), Ashley McEvoy (EVP), Thibaut Mongon (VP), William Perez (Director), Timothy Schmid (EVP, Worldwide Chairman, MedTech), Michael Sneed (COO), Paulus Stoffels (VP), James Swanson (EVP), Jennifer Taubert (EVP), Mark Weinberger (Director), Kathryn Wengel (EVP), Joseph Wolk (CFO), and Joseph Wolk (Exec. VP & CFO ). Learn More on Johnson & Johnson's active insiders.
Are insiders buying or selling shares of Johnson & Johnson?: During the last year, Johnson & Johnson insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $147,220.00. During the last year, insiders at the sold shares 3 times. They sold a total of 13,037 shares worth more than $2,154,035.67. The most recent insider tranaction occured on February, 25th when VP Robert J Decker sold 6,999 shares worth more than $1,160,994.12. Insiders at Johnson & Johnson own 0.2% of the company. Learn More about insider trades at Johnson & Johnson.
Information on this page was last updated on 2/25/2025.

Dominic J. Caruso Insider Trading History at Johnson & Johnson

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/20/2017	Sell	82,591	$136.72	$11,291,841.52	226,693
7/26/2016	Sell	41,146	$125.01	$5,143,661.46	157,819
7/18/2013	Sell	30,000	$90.31	$2,709,300.00

Dominic J. Caruso Buying and Selling Activity at Johnson & Johnson

Johnson & Johnson Company Overview

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Today's Range

Now: $163.63

$162.91

$164.52

50 Day Range

MA: $158.68

$145.39

$167.57

2 Week Range

Now: $163.63

$140.68

$169.99

Volume

5,760,266 shs

Average Volume

7,625,268 shs

Market Capitalization

$394.32 billion

P/E Ratio

24.61

Dividend Yield

3.08%

Beta

0.47